Literature DB >> 11929400

Serum pepsinogen and gastrin levels in HIV-positive patients: relationship with CD4+ cell count and Helicobacter pylori infection.

P Fabris1, A Pilotto, L Bozzola, G Tositti, G Soffiati, V Manfrin, F de Lalla.   

Abstract

BACKGROUND: The relationship between serum parameters of gastric function and Helicobacter pylori infection in human immunodeficiency virus (HIV)-positive patients is almost unknown. AIMS: To investigate in HIV-infected patients: (i) the relationship between serum gastrin and serum pepsinogens over the progressive phases of HIV-related disease; (ii) the impact of H. pylori infection on gastrin and pepsinogen serum levels and its relation to antral histology; (iii) the prevalence of parietal cell autoantibodies.
METHODS: Fifty-nine HIV-positive patients were studied by upper endoscopy plus gastric antral biopsy. Serum samples were tested for gastrin, pepsinogen A, pepsinogen C and parietal cell autoantibodies.
RESULTS: In patients without overt acquired immunodeficiency syndrome (AIDS), or with a CD4+ count of > 100 x 10(6) cells/L, mean serum levels of gastrin and pepsinogen C were higher than in subjects with AIDS or with a CD4+ count of < 100 x 10(6) cells/L (P < 0.01). Only one patient was found to be positive for parietal cell autoantibodies. H. pylori infection was associated with increased values of gastrin and pepsinogen C only in HIV-positive patients without AIDS or with a CD4+ count of > 100 x 10(6) cells/L. Atrophy was more frequent in patients with overt AIDS than in those without overt AIDS (57% vs. 33%, P=N.S.), and/or in patients with a CD4+ count of < 100 x 10(6) cells/L than in those with a CD4+ count of > 100 x 10(6) cells/L (62% vs. 26%, P < 0.05).
CONCLUSIONS: HIV-positive patients without overt AIDS have increased serum levels of gastrin and pepsinogen C compared with HIV-positive patients with overt AIDS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929400     DOI: 10.1046/j.1365-2036.2002.01234.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  5 in total

1.  Gastric mucosal hyperplasia via upregulation of gastrin induced by persistent activation of gastric innate immunity in major histocompatibility complex class II deficient mice.

Authors:  T Fukui; A Nishio; K Okazaki; N Uza; S Ueno; M Kido; S Inoue; H Kitamura; K Kiriya; S Ohashi; M Asada; H Tamaki; M Matsuura; K Kawasaki; K Suzuki; K Uchida; H Fukui; H Nakase; N Watanabe; T Chiba
Journal:  Gut       Date:  2005-12-01       Impact factor: 23.059

2.  Coinfection: Helicobacter pylori/human immunodeficiency virus.

Authors:  Martin Olmos; Valentina Araya; Eduardo Pskorz; Eduardo Coronado Quesada; Hugo Concetti; Hector Perez; Pedro Cahn
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

3.  A low prevalence of H pylori and endoscopic findings in HIV-positive Chinese patients with gastrointestinal symptoms.

Authors:  Fu-Jing Lv; Xiao-Lan Luo; Xin Meng; Rui Jin; Hui-Guo Ding; Shu-Tian Zhang
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

4.  Low prevalence of H. pylori infection in HIV-positive patients in the northeast of Brazil.

Authors:  Andréa B C Fialho; Manuel B Braga-Neto; Eder J C Guerra; André M N Fialho; Karine C Fernandes; Juliana L M Sun; Christianne F V Takeda; Cícero I S Silva; Dulciene M M Queiroz; Lucia L B C Braga
Journal:  BMC Gastroenterol       Date:  2011-02-19       Impact factor: 3.067

5.  Helicobacter pylori, HIV and Gastric Hypochlorhydria in the Malawian Population.

Authors:  Joe Geraghty; Alexander Thumbs; Anstead Kankwatira; Tim Andrews; Andrew Moore; Rose Malamba; Neema Mtunthama; Kai Hellberg; Lughano Kalongolera; Paul O'Toole; Andrea Varro; D Mark Pritchard; Melita Gordon
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.